Phenotypic Differences in Thyroid Immune Related Adverse Events Following Treatment With Immune Checkpoint Inhibitors

Background: Thyroid toxicity is common following immune checkpoint inhibitor (ICI) treatment. Published studies estimate the incidence at 10-20%, although rates vary widely between different ICIs. The etiology of ICI-associated thyroid immune related adverse events (irAEs) is unknown & not all p...

Descripción completa

Detalles Bibliográficos
Autores principales: Muir, Christopher Alan, Menzies, Alexander M, Clifton-Bligh, Roderick John, Long, Georgina V, Scolyer, Richard A, Tsang, Venessa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Thyroid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265849/
http://dx.doi.org/10.1210/jendso/bvab048.1790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265849/
http://dx.doi.org/10.1210/jendso/bvab048.1790

Ejemplares similares